Growth Metrics

ImmunityBio (IBRX) Gross Profit (2023 - 2026)

ImmunityBio (IBRX) reported Gross Profit of $44.0 million for Q1 2026, up 167.14% year-over-year from $16.5 million in Q1 2025, and up 16.0% on a QoQ basis from $37.9 million in Q4 2025.

ImmunityBio (IBRX) has 4 years of Gross Profit data on file, last reported at $44.0 million in Q1 2026.

  • Quarterly Gross Profit rose 167.14% year-over-year to $44.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $140.0 million (up 349.38% YoY) and the FY2025 annual result came in at $112.5 million, up 663.21% from the prior year.
  • Gross Profit rose to $44.0 million in Q1 2026 per IBRX's latest filing, from $37.9 million in the prior quarter.
  • Across five years, Gross Profit topped out at $44.0 million in Q1 2026 and bottomed at $40000.0 in Q1 2024.
  • The 4-year median for Gross Profit is $6.8 million (2024), against an average of $14.3 million.
  • The widest annual swing landed in 2025, when Gross Profit soared 41047.5%; it then soared 167.14% in 2026.
  • Tracing IBRX's Gross Profit over 4 years: stood at $139000.0 in 2023, then jumped by 5333.09% to $7.6 million in 2024, then jumped by 401.89% to $37.9 million in 2025, then climbed by 16.0% to $44.0 million in 2026.
  • Per Business Quant, the three latest IBRX Gross Profit figures stand at $44.0 million (Q1 2026), $37.9 million (Q4 2025), and $31.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 ImmunityBio 7.72 Bn 7.34 Bn 43.97 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 43.97 Mn
Mar 31, 2026 43.97 Mn
Dec 31, 2025 37.90 Mn
Dec 31, 2025 37.90 Mn
Sep 30, 2025 31.88 Mn
Sep 30, 2025 31.88 Mn
Jun 30, 2025 26.29 Mn
Jun 30, 2025 26.29 Mn
Mar 31, 2025 16.46 Mn
Mar 31, 2025 16.46 Mn
Dec 31, 2024 7.55 Mn
Dec 31, 2024 7.55 Mn
Sep 30, 2024 6.11 Mn
Sep 30, 2024 6.11 Mn
Jun 30, 2024 1.05 Mn
Jun 30, 2024 1.05 Mn
Mar 31, 2024 40,000.00
Mar 31, 2024 40,000.00
Dec 31, 2023 139,000.00
Dec 31, 2023 139,000.00
Sep 30, 2023 82,000.00
Sep 30, 2023 82,000.00
Jun 30, 2023 41,000.00
Jun 30, 2023 41,000.00